Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatment
Authors:
- 1 October 2018
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 44 (10) , 1646-1656
Abstract
No abstract availableKeywords
Funding Information
- University of Heidelberg medical faculty
This publication has 34 references indexed in Scilit:
- Significance of Histopathological Tumor Regression After Neoadjuvant Chemotherapy in Gastric AdenocarcinomasAnnals of Surgery, 2011
- 7th Edition of the AJCC Cancer Staging Manual: StomachAnnals of Surgical Oncology, 2010
- Evaluation of the Seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classificationCancer, 2010
- Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomasLaboratory Investigation, 2009
- Worldwide esophageal cancer collaborationDiseases of the Esophagus, 2009
- Refining Esophageal Cancer Staging After Neoadjuvant Therapy: Importance of Treatment ResponseAnnals of Surgical Oncology, 2008
- Long-term Outcomes Following Neoadjuvant Chemoradiotherapy for Esophageal CancerAnnals of Surgery, 2007
- American Joint Committee on Cancer Staging System Does Not Accurately Predict Survival in Patients Receiving Multimodality Therapy for Esophageal AdenocarcinomaJournal of Clinical Oncology, 2007
- The Effects of Neoadjuvant Chemoradiation on pTNM Staging and Its Prognostic Significance in Esophageal CancerJournal of Gastrointestinal Surgery, 2006
- Pathologic Nodal Status Predicts Disease-Free Survival After Neoadjuvant Chemoradiation for Gastroesophageal Junction CarcinomaAnnals of Surgical Oncology, 2006